• Vertex Pharmaceuticals' (VRTX) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

    المصدر: Buzz FX / 11 فبراير 2025 09:56:10   America/Chicago


    Vertex Pharmaceuticals' (VRTX) "Overweight" Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Vertex Pharmaceuticals ( NASDAQ:VRTX - Get Free Report ) 's stock had its "overweight
    Read more...
شارك على،